Concepedia

Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule

Heidi Hörig, David S. Lee, William R. Conkright, Joe Divito, Henry Hasson, Audrey Rivera, David Park, John A. Tine, K P Guito, Kwong Wong-Yok Tsang,

Cancer Immunology Immunotherapy · 2000 · 208 citations · 11 references

DOIFull text

Open access

Concepts

References

11

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

Matthew L. Albert, Birthe Sauter, Nina Bhardwaj · Nature · 1998 · 2.3K citations

, , +16

Tolerance, Danger and the Extended Family

P. Matzinger · Annual Review of Immunology · 1994 · 334 citations

, , +17

Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE

Stephen D. Miller, Carol L. Vanderlugt, Deborah J. Lenschow et al. · Immunity · 1995 · 317 citations · Full text

, , +14

A Phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen.

Michael A. Morse, Yuping Deng, D Coleman et al. · PubMed · 1999 · 300 citations

, , +17

Carcinoembryonic Antigen in Histopathology: Immunoperoxidase Staining of Conventional Tissue Sections2

David M. Goldenberg, Robert M. Sharkey, F. James Primus · JNCI Journal of the National Cancer Institute · 1976 · 222 citations

, , +16